Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enhanced Recovery After Urologic Surgery: Regional vs Conventional Anesthesia
NCT06789744Not yet recruiting
- Start
- Feb 2025
- Primary completion
- May 2025
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Randomised, double-blind trial of liposomal bupivacaine and ropivacaine hydrochloride liposomal suspension injection in postoperative pain (5 arms). Primary endpoint: Numerical Rating Scale Pain Score at 24 hours. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
liposomal bupivacaineropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06789744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06789744.